Using a discovery approach combining experimental models and unbiased computational analysis complemented by validation in patient biospecimens, we identified a nuclear-enriched lncRNA (<i>AC004540.4</i>) that is upregulated in NRAS/MAPK-dependent melanoma, and that we named <i>T-RECS</i>. Here, NRAS is linked to melanoma.